Newsbenzinga
Vaxcyte Narrows Timing Of Topline Data From VAX-31 Adult Phase 3 OPUS-1 Trial To End Of October 2026 From Q4 2026
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…